O. Turriziani, M. Andreoni, G. Antonelli 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Vaccines for the elderly
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines.
High prevalence of azithromycin resistance to Treponema pallidum in geographically different areas in China  X.-S. Chen, Y.-P. Yin, W.-H. Wei, H.-C. Wang,
Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following.
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Salvage therapy for multidrug-resistant tuberculosis
Approach to diagnosis of infective endocarditis
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Virological tools to diagnose and monitor hepatitis C virus infection
Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16α-bromoepiandrosterone (HE2000)  C. Reading,
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Drug-resistant human immunodefiency virus
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage.
Vector control: a cornerstone in the malaria elimination campaign
The role of vaccination in preventing pneumococcal disease in adults
Training for the infectious diseases speciality in Norway
CMI editorial report 2011 Clinical Microbiology and Infection
Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Salvage therapy for multidrug-resistant tuberculosis
V Duque, ÁA. Holguín, M. Silvestre, J. GonzÁAlez-Lahoz, V. Soriano 
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Hepatitis B and C virus-related carcinogenesis
T.M. File  Clinical Microbiology and Infection 
New developments in laboratory monitoring of HIV-1 infection
Update on antifungal resistance in Aspergillus and Candida
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Antimicrobial drug development – the past, the present, and the future
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Vaccines for the elderly
F. Ceccherini-Silberstein, V. Cento, V. Calvez, C.-F. Perno 
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
Diagnostic value of quantitative PCR for adenovirus detection in stool samples as compared with antigen detection and cell culture in haematopoietic stem.
An after-hours clinical liaison blood culture service—is it worth it?
C. Wongsrichanalai, C.H. Sibley  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo 
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Are we losing the fight against malaria one more time?
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
New patterns of HIV-1 resistance during HAART
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection  O. Turriziani, M. Andreoni, G. Antonelli  Clinical Microbiology and Infection  Volume 16, Issue 10, Pages 1518-1524 (October 2010) DOI: 10.1111/j.1469-0691.2010.03329.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Main cellular reservoirs of human immunodeficiency virus type 1 (HIV-1) drug-resistant variants in the blood compartment. Following HIV-1 binding to different blood cells, the viral genome is reverse transcribed into DNA. Infection of activated CD4+ T-cells leads to pronounced production of virions, and eventually to cell death, because of either the cytopathic effect (CPE) of the virus or cytotoxic T lymphocytes (CTL) activity. Two populations of resting CD4+ T-cells exist, the naïve and the memory cells. It has been hypothesized that the memory CD4+ T-cells, which carry the pro-virus, are infected while they are in the process of reverting to the resting state. On activation, these cells are able to release the drug-resistant archived variants. The contribution of naïve cells to the dissemination of the virus is less clear. In monocytes, HIV-1 replicates at low levels, and infection has no impact on monocyte viability. Clinical Microbiology and Infection 2010 16, 1518-1524DOI: (10.1111/j.1469-0691.2010.03329.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions